emealia docs · internal 2026-09-11

What the market actually allows

An honest, from-scratch reading of where emealia can realistically stand — built only from independent and primary sources, and deliberately without any “better than X” claim. The task here is not to confirm the plan; it is to state the chances plainly, including the uncomfortable parts.

Built 11 September 2026 · supersedes earlier competitor rounds · every figure carries a source · sources at the end

The starting conditions

Four facts set the frame before any positioning question. None is fatal; together they define the difficulty.

€114→267M
DE nutrition-app revenue 2024→2030, ~15%/yr (Grand View). Small market; US ~5× larger.
calorie apps in one directory; >1M new apps expected on the App Store in 2026 — while downloads grew only +2%.
health-app users kept past month 1; ~3% by day 30. Ratings (often 4.5★) come from the few who fit — not the many who leave.
<50%
of Germans willing to pay for a health app (Deloitte 2026). “kostenlos” is as large a search term as the base term.
The honest frame

Being found at all is the bottleneck, not the product. A better app is not discovered by default in a market adding a million apps a year against flat demand. For a one-person, web-only product with no ad budget, that is the hardest single fact — and the one the positioning has to answer first.

Why people quit tracking — and what emealia is built around

This is the strongest case for emealia, and it needs no competitor. Food tracking fails for four documented reasons. Each of emealia’s core choices answers one of them. That is a self-standing argument.

Why people quitEvidenceemealia’s design answer
Perfection pressure — one missed meal feels like failure, so they stopDetailed tracking is associated with disordered eating (Levinson 2017: 73% of affected users said the app contributed); red “over budget” visuals produce intense negative emotion (BJPsych Open 2021)No red, no streaks to break, ranges instead of point numbers — “27 or 32 g of oats, roughly 30”
Logging fatigue — “when tracking takes longer than eating, most people give up”The founding pain of the whole categoryOne sentence of plain text, parsed against official data — no search-and-select flow
Numbers without meaning — raw calorie counts feel hollowUsers abandon data that doesn’t tell them anythingContributions / coverage: what a food added, not whether it was “good”
Messy real life — home-cooked, restaurant, potluck don’t fit precise systemsPrecise logging can’t represent an approximate mealApproximate free-text handles any meal; exactness is optional, not required
Why this matters

Diet plans fail too: a 45-trial review found little effect past 24 months and up to 60% regaining all lost weight (Frontiers 2018). That is the evidence base for emealia’s “small nudge, not a plan” instinct — and it lets emealia make its case from the category’s own failure data, never from “we beat app X.”

What does not set emealia apart

Positioning must not lean on these. They were assumed to be differentiators; on inspection they are widely held or already occupied. Naming them protects against a false claim later.

What the market searches for

Real German search volumes (Keyword Planner, Aug 2025–Jul 2026). The demand sits in the mainstream words emealia de-emphasises; emealia’s own vocabulary is barely searched.

~5,000 / mo (the demand)~500~50~0
kalorienzähler · kalorienzähler kostenlos · kalorien zählen app · kalorien tracken · abnehm app · ernährungstagebuch abnehmen ohne kalorien zählen · calorie counter app · essenstagebuch ernährungstracker · makro tracker · nährwerte app · intuitive eating app · achtsam essen app (−100% YoY) food journal no calories · kalorien zählen ohne wiegen · essen ohne schlechtes gewissen · ozempic ernährung app
The value question, honestly

The values emealia stands for — no pressure, no judgement — are in demand, but the demand shows up as abandonment of harsh tracking, not as search terms. So those values convert and retain; they do not get you found. And “without counting” is the wrong frame anyway — you always record something. The real idea is “approximate is enough” (round vs. precise goals show no difference in outcome, Frech 2022).

What emealia can stand on — its own claims, provable

Absolute claims emealia can demonstrate with a test a user runs themselves — no comparison required, and nothing that can’t be substantiated.

Claim 1Speed you can time

“Write down your whole day in a sentence.”

How long does one evening entry for the whole day take? A restaurant meal? Measure it and publish the seconds — an absolute number, not “faster than.” This directly answers the top quit-reason (logging fatigue). Caveat to keep honest: voice logging elsewhere is marketed at ~10 s, so the claim is “fast and calm,” not “fastest possible.”

Claim 2Approximate, but grounded

“Rough numbers from real national food data — and it tells you when it’s a guess.”

Numbers come from official databases; where a food is unknown, a labelled estimate is shown and later human-checked. Provable in the product itself — the label is visible. The quality comes from the data behind it, which is the part to protect from overclaim.

Claim 3No judgement, by design

“It never turns red on you.”

No red, no streak to lose, no verdict. Provable because the product simply never does it — and it maps onto the perfection-pressure quit-reason.

Claim 4Privacy as a product value

“No ads, nothing sold, data in the EU.”

Germans place the highest value on privacy of six countries measured — e.g. bank-balance data worth €15.43/mo to protect vs €4.99 in the US (Prince & Wallsten). So “no ads, no data sale, EU servers” is worth paying for in DE/EU specifically — and much less so in the US. A concrete reason to weight the German and EU markets.

The discipline

Prove a claim with a test the user can run, never with a comparison that isn’t substantiated. Comparative positioning against far larger players tends to backfire and give them oxygen; it also invites the exact overclaim that has tripped this project before.

Engagement without the harm

“No streaks” forgoes a proven engagement lever (streaks/gamification lift engagement ~40%). But punishing streaks also drive people away. There is an evidence-based middle — so this is not a straight sacrifice.

Discovery for a web-only product

emealia will ship as a web app. App-store findability is therefore irrelevant; the channels are different — and the keyword demand above matters more, because Google search becomes the front door.

The founder and privacy as trust — not as growth

An honest ledger of what the founder story does and does not do for the business.

Genuine asset

  • Real founder-market fit: Hashimoto, a hard pregnancy, postpartum iron deficiency, being overwhelmed by conflicting advice — the person emealia is built for.
  • Women’s health is large, underserved and investable (a ~$1T gap by 2040; funding grew even in a down market). Credibility here is real.
  • Against an anonymous, tool-generated app flood, a named person with a story is a trust and durability signal — problem-driven builders don’t burn out the way clone-factories do.
  • Privacy premium in Germany makes “no ads, no data sale” a paid-for value, not a slogan.

Not a growth engine

  • “Build in public” brings followers, not customers — the people who cheer milestones aren’t always the ones who pay.
  • It does not fix discovery or the payment barrier on its own.
  • The app being AI-assisted (“vibe-coded”) is fine only with the invisible engineering the flood skips — tests, auth, rate-limits, error tracking (audits found 23 of 26 such apps had no tests). Being a technical founder is exactly what makes that discipline possible; it is not automatic.

Which markets, and the price question

Core
Where the values are worth paying for.
DE / DACH & privacy-conscious EUPrivacy premium, German-data accuracy, fastest-growing EU market. A web app makes multi-country cheaper (no per-store localisation).
Plausible
Second, not first.
CanadaBilingual, official CNF data already held, smaller and less saturated than the US.
Hardest
Largest but least suited to a paid solo product.
United StatesBiggest market, but lowest willingness to pay for privacy, most saturated, most free-tolerant.

Price, honestly. emealia is paid (subscription + a credits option), with no free-forever tier. On price it sits fairly against the paid tiers (roughly €5–10/month). The harder competition is the free tiers: a capable free tier already gives official data and nutrients at no cost, and “free” is a top search term. So the real question is not “why pay instead of nothing” but what the paid experience gives that a free tier doesn’t — calm speed, no judgement, German-data accuracy, privacy — and whether the credits model lowers the German payment barrier. Unproven; test it early.

The three bets everything rests on

  1. Does the weekly read-back actually teach anyone anything? The retention core. Five user interviews settle it.
  2. Do credits + “try without payment data” carry the German payment barrier against strong free tiers?
  3. Is there a warm way in — a niche community or women’s-health media route that turns the founder story into first users?
If one fails

The path bends or breaks. That is not pessimism; it is the condition for spending effort honestly. None of these is proven today.

Honest verdict

Stated as plainly as the evidence allows:

Themes to validate, not assume

Real pains that appear in feedback and forums, but are not yet sized markets. Treat as design themes and verify with interviews before building around them — and search the theme, not the single example.

Sources

Full working analysis with per-claim source tags and confidence: emealia-faktenbasis-phase1.md and emealia-positionierung-phase2.md (project docs).